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and Osamu Mimura1Abstract
Background: Refractive change can be caused by systemic illnesses such as Lupus erythematosus, thyroid
deficiency, and diabetes mellitus. However, refractive change after pituitary tumor removal has so far not been
reported.
Case presentation: A 62-year-old woman presented with blurred near vision 10 days after trans-sphenoidal surgery
(TSS) for a pituitary tumor. Around the same time, she experienced intercurrent hyponatremia. The corrected visual acuity
of both eyes was 20/20, the spherical equivalent of the right eye was −2.125 diopters, and of the left eye was −2.0
diopters before TSS. However, 11 days after TSS, the spherical equivalent of the right eye changed to −0.75 diopters, and
that of left eye changed to −1.125 diopters without hyperglycemia. There were no changes in the corrected visual acuity
during the follow-up.
Conclusion: We demonstrated a case with transient refractive change after TSS. The following mechanism is proposed:
Hyponatremia induced by the pituitary tumor removal causes an osmotic change in the aqueous humor with lens
swelling. This case report is a reminder to both ophthalmologists and neurosurgeons that ophthalmological factors such
as lens thickness and axial length should be taken into account when conducting preoperative examinations especially
for patients undergoing TSS.
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Refractive change of the eye is affected by a combination
of axial length, corneal power anterior chamber depth and
lens power. In general, refraction changes with age. In a
recent report about lens power and refractive error, the
axial length and the lens power was found to influence
the refractive error mostly in adults aged over 50 [1,2].
Refractive change is often described in systemic illness
such as Lupus erythematosus [3], thyroid deficiency [4],
pregnancy, orbital tumor [5], and diabetes mellitus
(DM). Refractive change has been recognized in DM
since the 19th century and was well-described through-
out the 20th century [6-10].* Correspondence: ohmyeye@hyo-med.ac.jp
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reproduction in any medium, provided the orThe pathologic occurrence of refractive change falls
under two patterns: one is lens thickness changing due
to an abnormal metabolic process, and the second is a
change of eye ball shape caused by an increase of orbital
contents. Lupus erythematosus and DM cause abnormal
water metabolism and influx of aqueous humor from
the anterior chamber into the lens, culminating in an
increased lens thickness [3,6-10]. Thyroid deficiencies
and orbital tumors increase orbital contents due to in-
flammation or a tumor, compressing the eye ball. As a
result, the eye ball shape is altered, which in turn pro-
duces refractive change [4,5].
To date, refractive change in hyponatremia after trans-
sphenoidal surgery (TSS) has never been reported. In
this case, we report the refractive change following TSS,
and discuss the causal correlation between refractive
change and hyponatremia.l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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A 62-year-old woman complaining of dizziness was ad-
mitted to our college hospital. The patient had a past
medical history of thyroid dysfunction. She was neuro-
logically intact, and had no abnormalities in her blood
tests. Magnetic resonance imaging (MRI) showed an
extended intrasellar tumor, which measured 25-mm in
its greatest diameter and did not attach to the optic
chiasm. The lesion infiltrated the right cavernous
sinus, and extended to the pharynx (Figure 1a). Ini-
tially, the tumor was considered to be a nonfunctional
pituitary adenoma.
The patient consented to TSS, and TSS was per-
formed without incident (Figure 1b). Seven days after
TSS, the patient presented with associated hyponatre-
mia (Figure 2). Approximately, 10 days after TSS, the
patient complained of blurred near vision.
In the ophthalmological examination before TSS, her
vision was almost completely intact without visual field
loss. The corrected visual acuity of both eyes was 20/
20, the spherical equivalent of the right eye was −2.125
diopters, and that of the left eye was −2.0 diopters be-
fore TSS. However, 11 days after TSS, the spherical
equivalent of the right eye had changed to −0.75 diop-
ters, and that of the left eye had changed to −1.125 di-
opters. Figure 2 shows the time course of serum
electrolyte and glucose levels, corneal radius, spherical
equivalent, axial length, anterior chamber depth, and
lens thickness of both eyes. Axial length, anterior
chamber depth and lens thickness were calculated by
A-mode ultrasonography. Lens power was calculatedFigure 1 Brain MRI. MRI of pre- (a) and post-operative pituitary tumor (b)with Bennett’s formula [11] at the onset of blurred vi-
sion (11 days after surgery) and follow up (264 days),
but could not be calculated before onset (i.e. before
surgery and upto 10 days after) because we did not cal-
culate axial length, anterior chamber depth and lens
thickness over this time frame. There were no changes
in axial length during follow up; however, both spher-
ical equivalent and lens thickness were decreased,
while in contrast the anterior chamber depth was in-
creased. In addition, the size of both the decrease in
lens thickness and the increase in anterior chamber
depth was the same. The lens power (right eye: 17.52
diopters, left eye: 18.30 diopters) at onset increased to
20.27 diopters (right eye) and 20.11 diopters (left eye)
at follow up (Table 1). Although her hyponatremia rap-
idly improved over a period of one week, the refractive
change persisted for 6 weeks (43 days) after TSS and
4 weeks after onset. During her 7 months of follow-up,
the level of serum glucose was not changed from a
normal and the patient had no apparent recurrence.
And also, the corrected visual acuity was not changed
during the follow-up.
Discussion
Many ophthalmological reports have documented tran-
sient refractive change in systemic illness. However,
this report is the first to present the hyperopia after
TSS with hyponatremia. In DM, the main mechanism
underlying refractive change has been implicated in
which decreasing osmotic pressure of the aqueous
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Figure 2 Patient findings. The time course of serum electrolyte levels, anterior chamber depth (d1), lens thickness (d2), spherical equivalent (SE),
axial length (AL), averaged corneal radius (CR) and corneal power (F1) of both eyes (RE; right eye, LE; left eye). Both spherical equivalent and lens
thickness values at onset are higher than at follow up, while in contrast the anterior chamber depth value is lower.
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eyes in the first visit was −2.06 diopters, at the time
of initial complaint of blurred near vision was −0.95 di-
opters, and at approximately 6 months after onset had
returned to the initial level. During the same timeperiod, the average lens thickness of both eyes upon
onset was 4.1 mm, and decreased to 3.9 mm 6 months
after onset, implying that the lens was swelling and
reverted to the initial thickness by 6 months. The pa-
tient exhibited no change in axial length throughout
Table 1 Changing of the factors related to the refractive change
At onset d1: anterior chamber depth d1: Lens thickness Lens posterior Pole FL: lens power
RE 3.05 mm 4.21 mm 7.26 mm 17.52 diopters
LE 3.1 mm 4.03 mm 7.13 mm 18.30 diopters
At follow up
RE 3.34 mm 3.89 mm 7.23 mm 20.27 diopters
LE 3.23 mm 3.9 mm 7.13 mm 20.11 diopters
Difference (onset minus follow up)
RE −0.29 mm 0.32 mm 0.03 mm −2.75 diopters
LE −0.13 mm 0.13 mm 0 mm −1.81 diopters
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this case was that hyperopia and hyponatremia oc-
curred simultaneously after TSS.
We found increased lens thickness and hyperopic
shift after the hyponatremia in the present study.
There are some concerns about the relationship be-
tween the refractive change and the related factors.
Generally, increased lens thickness alone should result
in a myopic shift.
Firstly, we need to consider the ciliary processes and
the position of the lens. The anterior shift of the lens-
iris diaphragm was able to cause myopia [12]. The
posterior pole of the lens calculated as anterior cham-
ber depth + lens thickness did not change during the
study period (Table 1). The increase in lens thickness
caused by hyponatremia matches the decrease in
anterior chamber depth. If the lens swelling in its pos-
ition is sustained by the zonule and the ciliary pro-
cesses, the amount of a backward movement of the
posterior pole could be at least equal to half the in-
crease in lens thickness. With increasing age, the pos-
terior pole recedes a little and the anterior chamber
decreases by a similar amount leaving the lens in its
usual position [13]. However, the present case showed
that the posterior pole of the lens did not recede, sug-
gesting that the refractive change was not due to
changes in lens position.
Next, we consider both the corneal power and lens
power during follow up. The corneal power was not
changed. In contrast, the lens power at onset was less
than during follow up according to Bennett’s formula
(Table 1), suggesting that the lens has lost the power
with swelling.
Conclusions
Preoperative ophthalmologic examination before TSS
is common. Routine examinations measure visual acu-
ity, visual fields, and ocular pressure. However, we
rarely get the opportunity to evaluate lens thicknessand axial length. In this case, the hyperopic shift was
caused by an increase in the lens thickness. Factors
such as lens thickness and axial length should be taken
into account when conducing preoperative ophthal-
mologic examinations especially for patients under-
going TSS.Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor of this journal.
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